FeaturesSignalPricingFounders
Log inGet started free
TA

Three Arch Partners

Venture CapitalActive

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as

Portola Valley, United StatesFounded 1993threearchpartners.com
114
Investments
6
Exits
$1.2B
AUM
5.3%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Three Arch Partners.

Get started free

Investment Thesis & Strategy

Three Arch Partners invests in fintech companies across various stages, providing them with clinical and business resources to support growth.

Investment Activity

Deals per year over the last 12 years

1
2000
0
2001
0
2002
0
2003
0
2004
0
2005
1
2006
3
2007
1
2008
0
2009
0
2010
1
2011

Portfolio Companies

Selected investments from their portfolio of 114 companies

T
Threshold Pharmaceuticals
Biotech · Growth, 0
Active
C
Corcept Therapeutics
Biotech · Growth, 0
Active
D
Dermira
Biotech · Growth, 2011
Active
E
Esperion Therapeutics
Biotech · Growth, 2008
Active
Z
Zosano Pharma
Biotech · Growth, 2007
Active
A
Ardian
Biotech · Growth, 2007
Active
A
AcelRx Pharmaceuticals
Biotech · Growth, 2007
Active
P
Portola Pharmaceuticals
Biotech · Growth, 2006
Active
S
Sequenom
Biotech · Growth, 2000
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Obsidian TherapeuticsIPO2024
Nektar TherapeuticsAcquisition2020
Avenue TherapeuticsIPO2020
Corvus PharmaceuticalsIPO2016
SequentaAcquisition2015
ProteolixAcquisition2013

Frequently Asked Questions

Three Arch Partners focuses on Series A, Series B, Series C+ stage investments.

Related Investors